PLIANT THERAPEUTICS, INC. Defined Contribution Plan, Cost
PLIANT THERAPEUTICS, INC. (PLRX) reported Defined Contribution Plan, Cost of $100.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:DefinedContributionPlanCostRecognized · last filed 2026-08-11
- PLIANT THERAPEUTICS, INC. defined contribution plan, cost for the quarter ending 2026-06-30 was $100.00K, a 66.67% decline year-over-year.
- PLIANT THERAPEUTICS, INC. defined contribution plan, cost for the quarter ending 2026-03-31 was $400.00K, a 42.86% decline year-over-year.
- PLIANT THERAPEUTICS, INC. defined contribution plan, cost for the quarter ending 2025-12-31 was $100.00K.
- PLIANT THERAPEUTICS, INC. defined contribution plan, cost for the quarter ending 2025-09-30 was $200.00K, a 33.33% decline year-over-year.
- PLIANT THERAPEUTICS, INC. defined contribution plan, cost for fiscal 2025 was $1.30M, a 30.00% increase from fiscal 2024.
- PLIANT THERAPEUTICS, INC. defined contribution plan, cost for fiscal 2024 was $1.00M, a 0.00% change from fiscal 2023.
- PLIANT THERAPEUTICS, INC. defined contribution plan, cost for fiscal 2023 was $1.00M, a 25.00% increase from fiscal 2022.
- PLIANT THERAPEUTICS, INC. defined contribution plan, cost for fiscal 2022 was $800.00K, a 33.33% increase from fiscal 2021.
| Period end | Defined Contribution Plan, Cost 3 month | Defined Contribution Plan, Cost 6 month | Defined Contribution Plan, Cost 9 month | Defined Contribution Plan, Cost 12 month | Defined Contribution Plan, Cost 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | $100.00K 10-Q · filed 2026-08-11 | $500.00K 10-Q · filed 2026-08-11 | $600.00K derived: sum of 3 quarters · filed 2026-08-11 | $800.00K derived: sum of 4 quarters · filed 2026-08-11 | |
| 2026-03-31 | $400.00K 10-Q · filed 2026-05-11 | $500.00K derived: sum of 2 quarters · filed 2026-05-11 | $700.00K derived: sum of 3 quarters · filed 2026-05-11 | $1.00M derived: sum of 4 quarters · filed 2026-08-11 | |
| 2025-12-31 | $100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-11 | $300.00K derived: sum of 2 quarters · filed 2026-03-11 | $600.00K derived: sum of 3 quarters · filed 2026-08-11 | $1.30M 10-K · filed 2026-03-11 | |
| 2025-09-30 | $200.00K 10-Q · filed 2025-11-06 | $500.00K derived: sum of 2 quarters · filed 2026-08-11 | $1.20M 10-Q · filed 2025-11-06 | $1.10M derived: sum of 4 quarters · filed 2026-08-11 | |
| 2025-06-30 | $300.00K 10-Q · filed 2026-08-11 | $1.00M 10-Q · filed 2026-08-11 | $900.00K derived: sum of 3 quarters · filed 2026-08-11 | $1.20M derived: sum of 4 quarters · filed 2026-08-11 | |
| 2025-03-31 | $700.00K 10-Q · filed 2026-05-11 | $600.00K derived: sum of 2 quarters · filed 2026-05-11 | $900.00K derived: sum of 3 quarters · filed 2026-05-11 | $1.40M derived: sum of 4 quarters · filed 2026-05-11 | |
| 2024-12-31 | -$100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-11 | $200.00K derived: sum of 2 quarters · filed 2026-03-11 | $700.00K derived: sum of 3 quarters · filed 2026-03-11 | $1.00M 10-K · filed 2026-03-11 | $1.30M 10-K · filed 2025-03-03 |
| 2024-09-30 | $300.00K 10-Q · filed 2025-11-06 | $800.00K derived: sum of 2 quarters · filed 2025-11-06 | $1.10M 10-Q · filed 2025-11-06 | $1.30M derived: sum of 4 quarters · filed 2025-11-06 | |
| 2024-06-30 | $500.00K 10-Q · filed 2025-08-07 | $800.00K 10-Q · filed 2025-08-07 | $1.00M derived: sum of 3 quarters · filed 2025-08-07 | $1.20M derived: sum of 4 quarters · filed 2025-08-07 | |
| 2024-03-31 | $300.00K 10-Q · filed 2025-05-08 | $500.00K derived: sum of 2 quarters · filed 2025-05-08 | $700.00K derived: sum of 3 quarters · filed 2025-05-08 | $1.00M derived: sum of 4 quarters · filed 2025-05-08 | |
| 2023-12-31 | $200.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | $400.00K derived: sum of 2 quarters · filed 2025-03-03 | $700.00K derived: sum of 3 quarters · filed 2025-03-03 | $1.00M 10-K · filed 2025-03-03 | |
| 2023-09-30 | $200.00K 10-Q · filed 2024-11-07 | $500.00K derived: sum of 2 quarters · filed 2024-11-07 | $800.00K 10-Q · filed 2024-11-07 | $1.00M derived: sum of 4 quarters · filed 2025-03-03 | |
| 2023-06-30 | $300.00K 10-Q · filed 2024-08-07 | $600.00K 10-Q · filed 2024-08-07 | $800.00K derived: sum of 3 quarters · filed 2025-03-03 | $900.00K derived: sum of 4 quarters · filed 2025-03-03 | |
| 2023-03-31 | $300.00K 10-Q · filed 2024-05-06 | $500.00K derived: sum of 2 quarters · filed 2025-03-03 | $600.00K derived: sum of 3 quarters · filed 2025-03-03 | $800.00K derived: sum of 4 quarters · filed 2025-03-03 | |
| 2022-12-31 | $200.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | $300.00K derived: sum of 2 quarters · filed 2025-03-03 | $500.00K derived: sum of 3 quarters · filed 2025-03-03 | $800.00K 10-K · filed 2025-03-03 | |
| 2022-09-30 | $100.00K 10-Q · filed 2023-11-09 | $300.00K derived: sum of 2 quarters · filed 2023-11-09 | $600.00K 10-Q · filed 2023-11-09 | $600.00K derived: sum of 4 quarters · filed 2024-02-27 | |
| 2022-06-30 | $200.00K 10-Q · filed 2023-08-09 | $400.00K 10-Q · filed 2023-08-09 | $500.00K derived: sum of 3 quarters · filed 2024-02-27 | $600.00K derived: sum of 4 quarters · filed 2024-02-27 | |
| 2022-03-31 | $200.00K 10-Q · filed 2023-05-09 | $300.00K derived: sum of 2 quarters · filed 2024-02-27 | $400.00K derived: sum of 3 quarters · filed 2024-02-27 | $600.00K derived: sum of 4 quarters · filed 2024-02-27 | |
| 2021-12-31 | $100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $200.00K derived: sum of 2 quarters · filed 2024-02-27 | $400.00K derived: sum of 3 quarters · filed 2024-02-27 | $600.00K 10-K · filed 2024-02-27 | |
| 2021-09-30 | $100.00K 10-Q · filed 2022-11-08 | $300.00K derived: sum of 2 quarters · filed 2022-11-08 | $500.00K 10-Q · filed 2022-11-08 | $600.00K derived: sum of 4 quarters · filed 2022-11-08 | |
| 2021-06-30 | $200.00K 10-Q · filed 2022-08-08 | $400.00K 10-Q · filed 2022-08-08 | $500.00K derived: sum of 3 quarters · filed 2022-08-08 | $600.00K derived: sum of 4 quarters · filed 2022-08-08 | |
| 2021-03-31 | $200.00K 10-Q · filed 2022-05-09 | $300.00K derived: sum of 2 quarters · filed 2022-05-09 | $400.00K derived: sum of 3 quarters · filed 2022-05-09 | $500.00K derived: sum of 4 quarters · filed 2022-05-09 | |
| 2020-12-31 | $100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $200.00K derived: sum of 2 quarters · filed 2022-03-01 | $300.00K derived: sum of 3 quarters · filed 2022-03-01 | $400.00K 10-K · filed 2022-03-01 | |
| 2020-09-30 | $100.00K 10-Q · filed 2021-11-09 | $200.00K derived: sum of 2 quarters · filed 2021-11-09 | $300.00K 10-Q · filed 2021-11-09 | $400.00K derived: sum of 4 quarters · filed 2022-03-01 | |
| 2020-06-30 | $100.00K 10-Q · filed 2021-08-09 | $200.00K 10-Q · filed 2021-08-09 | $300.00K derived: sum of 3 quarters · filed 2022-03-01 | $400.00K derived: sum of 4 quarters · filed 2022-03-01 | |
| 2020-03-31 | $200.00K 10-Q · filed 2021-05-10 | $200.00K derived: sum of 2 quarters · filed 2022-03-01 | $300.00K derived: sum of 3 quarters · filed 2022-03-01 | $400.00K derived: sum of 4 quarters · filed 2022-03-01 | |
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $100.00K derived: sum of 2 quarters · filed 2022-03-01 | $200.00K derived: sum of 3 quarters · filed 2022-03-01 | $200.00K 10-K · filed 2022-03-01 | |
| 2019-09-30 | $100.00K 10-Q · filed 2020-11-10 | $200.00K derived: sum of 2 quarters · filed 2020-11-10 | $200.00K 10-Q · filed 2020-11-10 | ||
| 2019-06-30 | $100.00K 10-Q · filed 2020-08-11 | $100.00K 10-Q · filed 2020-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |